Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.4.a
Brinkmann EM et al. (2016) |
Xla Wt + frzb2 MO
NF10.5 (in situ hybridization) |
|
||||
fig.4.a
Brinkmann EM et al. (2016) |
Xla Wt + fzd7 MO
NF10.5 (in situ hybridization) |
|
||||
fig.4.c
Brinkmann EM et al. (2016) |
Xla Wt + fzd7 MO
NF10.5 (in situ hybridization) |
|
||||
fig.2.d
Brinkmann EM et al. (2016) |
Xla Wt + Hsa.sfrp2
NF11 (in situ hybridization) |
|
||||
fig.2.a, b, c
Brinkmann EM et al. (2016) |
Xla Wt + ror2 MO
NF11 (in situ hybridization) |
|
||||
fig.4.a
Brinkmann EM et al. (2016) |
Xla Wt + sfrp1 MO
NF10.5 (in situ hybridization) |
|
||||
fig.4.a,b
Brinkmann EM et al. (2016) |
Xla Wt + sfrp2 MO
NF10.5 (in situ hybridization) |
|
||||
fig.2.a, b, c, d
Brinkmann EM et al. (2016) |
Xla Wt + sfrp2 MO
NF11 (in situ hybridization) |
|
||||
fig.6.a
Martinez S et al. (2015) |
Xla Wt + ptk7del_1-2178-GFP + animal cap explant
NF13 (RT-PCR) |
|
||||
fig.6.a
Martinez S et al. (2015) |
Xla Wt + ptk7del_1-2178-GFP + animal cap explant
NF13 (RT-PCR) |
|